These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8981472)
41. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
44. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121 [TBL] [Abstract][Full Text] [Related]
45. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236 [TBL] [Abstract][Full Text] [Related]
46. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108 [TBL] [Abstract][Full Text] [Related]
47. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease. Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989 [TBL] [Abstract][Full Text] [Related]
48. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test. Kulkarni AP; Pillay NS; Kellaway LA; Kotwal GJ Biogerontology; 2008 Dec; 9(6):405-20. PubMed ID: 18679819 [TBL] [Abstract][Full Text] [Related]
49. Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. Jankowsky JL; Melnikova T; Fadale DJ; Xu GM; Slunt HH; Gonzales V; Younkin LH; Younkin SG; Borchelt DR; Savonenko AV J Neurosci; 2005 May; 25(21):5217-24. PubMed ID: 15917461 [TBL] [Abstract][Full Text] [Related]
50. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Walker JM; Fowler SW; Miller DK; Sun AY; Weisman GA; Wood WG; Sun GY; Simonyi A; Schachtman TR Behav Brain Res; 2011 Sep; 222(1):169-75. PubMed ID: 21443906 [TBL] [Abstract][Full Text] [Related]
51. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Yamaguchi F; Richards SJ; Beyreuther K; Salbaum M; Carlson GA; Dunnett SB Neuroreport; 1991 Dec; 2(12):781-4. PubMed ID: 1686563 [TBL] [Abstract][Full Text] [Related]
52. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease. Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701 [TBL] [Abstract][Full Text] [Related]
53. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629 [TBL] [Abstract][Full Text] [Related]
54. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Schmitt U; Hiemke C; Fahrenholz F; Schroeder A Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917 [TBL] [Abstract][Full Text] [Related]
55. Isoform-specific knockout of FE65 leads to impaired learning and memory. Wang B; Hu Q; Hearn MG; Shimizu K; Ware CB; Liggitt DH; Jin LW; Cool BH; Storm DR; Martin GM J Neurosci Res; 2004 Jan; 75(1):12-24. PubMed ID: 14689444 [TBL] [Abstract][Full Text] [Related]
56. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Bernardo A; McCord M; Troen AM; Allison JD; McDonald MP Neurobiol Aging; 2007 Aug; 28(8):1195-205. PubMed ID: 16837103 [TBL] [Abstract][Full Text] [Related]
57. Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage: A longitudinal study. Codita A; Gumucio A; Lannfelt L; Gellerfors P; Winblad B; Mohammed AH; Nilsson LN Behav Brain Res; 2010 Dec; 215(1):83-94. PubMed ID: 20615433 [TBL] [Abstract][Full Text] [Related]
58. The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice. Perucho J; Casarejos MJ; Rubio I; Rodriguez-Navarro JA; Gómez A; Ampuero I; Rodal I; Solano RM; Carro E; García de Yébenes J; Mena MA Exp Neurol; 2010 Jan; 221(1):54-67. PubMed ID: 19815012 [TBL] [Abstract][Full Text] [Related]
59. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Leighty RE; Nilsson LN; Potter H; Costa DA; Low MA; Bales KR; Paul SM; Arendash GW Behav Brain Res; 2004 Aug; 153(1):107-21. PubMed ID: 15219712 [TBL] [Abstract][Full Text] [Related]
60. Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. Bhoiwala DL; Koleilat I; Qian J; Beyer B; Hushmendy SF; Mathew A; Bhoiwala DL; Ferland RJ; Crawford DR Neurol Res; 2013 Jan; 35(1):79-89. PubMed ID: 23317802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]